BaseLaunch

15 months, 100% non-dilutive. Partners: J&J Innovation, Novartis Venture Fund, Pfizer, Roche, AbbVie, Takeda.

Profile being verified · Active right now

Stage
Seed
Ticket
Up to CHF 500K
Location
Basel
Tracked rounds
1

What they look for

THE Swiss biotech and pharma programme par excellence. 100% non-dilutive. Big pharma partners (J&J, Novartis, Pfizer, Roche, AbbVie, Takeda) give you direct access to pharma business development teams that could license or acquire you.

What puts them off

Non-biotech startup, no preclinical data, technology without a defined therapeutic application.

How to approach them

Application on baselaunch.ch. Very selective: 5–8 startups per cohort out of hundreds of applications.

Decision process

15 intensive months. Mentoring by scientific and pharma experts. No direct investment, but links with Novartis Venture Fund and others.

Recent investments

Alumni: Numab, Sophia Genetics (former alumni), Crispr Therapeutics. The best Swiss biotechs have passed through.

Rounds tracked by FundSwiss